United Therapeutics buy tamam
Start price
31.08.17
/
50%
€116.65
Target price
03.06.19
€150.63
Performance (%)
-35.27%
End price
03.06.19
€75.51
Summary
This prediction ended on 03.06.19 with a price of €75.51. The BUY prediction by tamam for United Therapeutics performed very badly with a performance of -35.27%. tamam has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| United Therapeutics | -1.329% | -1.329% | 12.419% | 67.782% |
| iShares Core DAX® | 1.927% | -2.112% | 11.138% | 59.636% |
| iShares Nasdaq 100 | -0.184% | -5.899% | -0.151% | 82.446% |
| iShares Nikkei 225® | 7.076% | 6.457% | 28.830% | 59.334% |
| iShares S&P 500 | -0.201% | -3.667% | -0.104% | 55.648% |
Comments by tamam for this prediction
In the thread United Therapeutics diskutieren
tamam stimmt dem Crowdsentiment von 'Buy' zu
tamam stimmt am 31.08.2017 dem Buy-Crowdsentiment mit dem Kursziel 167.0$ zu.
Eine Kurserholung drängt sich auf, da die
FDA rejects SteayMed's marketing application for lead candidate Trevyent for PAH!
(Vom Mitglied beendet)